Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery最新文献

{"title":"Does living in a food desert impact weight loss after bariatric surgery?","authors":"Lucas Keller-Biehl, Guilherme S Mazzini, Guilherme M Campos, Jennifer L Salluzzo","doi":"10.1016/j.soard.2024.10.036","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.036","url":null,"abstract":"<p><strong>Background: </strong>Lower access to fresh foods and lower income level are associated with greater obesity rates.</p><p><strong>Objectives: </strong>We aim to study if weight loss 1 year after bariatric surgery is associated with living in areas defined as food deserts, that is, low access to foods and lower income.</p><p><strong>Setting: </strong>Virginia Commonwealth University Hospital System, Richmond, VA; Academic Center.</p><p><strong>Methods: </strong>Review of consecutive patients who underwent primary bariatric surgery in a single institution. Patients were studied in groups based the USDA Economic Research Service classification: low access (>1 mile grocery urban setting or >10 miles rural setting), low income (poverty rate ≥20%, or family income <80% of state), food desert (low income and low access), and food secure (neither low income nor low access).</p><p><strong>Results: </strong>A total of 396 patients had surgery, 89% female, 51% Black. Among those patients, 133 (34%) had LRYGB and 263 (66%) LSG. Twenty-nine percent, 26%, 22%, and 23% were defined as low access, low income, food desert, or food secure, respectively. Factors independently associated with inferior excess BMI loss at 1 year were LSG, Black race, being single, and obstructive sleep apnea.</p><p><strong>Conclusions: </strong>Living in a food desert was not associated with inferior weight loss after bariatric surgery. It suggests that patients can overcome these barriers to attain appropriate weight loss 1 year after surgery.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comment on \"Roux-en-Y gastric bypass vs duodenal switch in patients with BMI ≥50 kg/m²: a systematic review and meta-analysis\".","authors":"Folahan Ayoola","doi":"10.1016/j.soard.2024.10.035","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.035","url":null,"abstract":"","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142901335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of calcium citrate and calcium carbonate absorption in patients with a Roux-en-Y gastric bypass, sleeve gastrectomy, and one-anastomosis gastric bypass: a double-blind, randomized cross-over trial.","authors":"Mohamed Hany, Stephanie Wuyts, Anwar Ashraf Abouelnasr, Ahmed Zidan, Hala M Demerdash, Heba Abdel Samie Mohamed Hussein, Ramy E Arida, Sherif Mohamed Elsharkawi, Cees Kramers, Bart Torensma","doi":"10.1016/j.soard.2024.10.034","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.034","url":null,"abstract":"<p><strong>Objective: </strong>This study compared the efficacy of calcium (Ca) citrate and Ca carbonate supplementation on Ca absorption following Roux-en-Y gastric bypass (RYGB), laparoscopic sleeve gastrectomy (LSG), and one-anastomosis gastric bypass (OAGB) surgeries.</p><p><strong>Setting: </strong>A single specialized bariatric center.</p><p><strong>Methods: </strong>A randomized, double-blinded, crossover study between October 2023 and February 2024. One hundred fifty participants 6 months postmetabolic bariatric surgery (MBS) were randomly selected from the electronic patient record system to create a pool of patients to randomize for the study. The intestinal absorption of Ca carbonate and Ca citrate among groups divided by surgical procedure was compared over 8 hours of testing. Measurements included serum and urine Ca concentrations for peak values (C_max) and area under the curve (AUC_0-8h), along with parathyroid hormone (PTH) levels to calculate minimum PTH (PTH_min) and cumulative PTH decline (AUC_0-8h).</p><p><strong>Results: </strong>In total, 50 per each surgery group were included with an average age of 40.5 ± 7.6 years, of whom 128 (85.3%) were female. The participants' average BMI was 30.3 ± 2.0 kg/m². The average time elapsed after MBS was 9.8 ± 1.0 months. Ca citrate intake significantly lowered PTH levels and showed enhanced relative Ca bioavailability compared to Ca carbonate. Specifically, PTH levels were notably reduced from 3 to 6 hours postadministration with Ca citrate, with significant differences (P < .001). Ca citrate also demonstrated superior relative bioavailability, as evidenced by a higher AUC_0-8h of 76.1 mg/dL·h versus 74.7 mg/dL·h for carbonate (P = .001) and a C_max of 9.8 mg/dL compared to 9.5 mg/dL for carbonate (P < .001). Additionally, urinary Ca excretion over 9 hours was significantly greater in the citrate group at 83.7 mg/dL compared to 68.6 mg/dL for carbonate (P < .001).</p><p><strong>Conclusion: </strong>The study demonstrates that Ca citrate was significantly better than carbonate in reducing PTH levels, enhancing relative Ca bioavailability, and increasing urinary Ca excretion. Additionally, Ca citrate resulted in higher cumulative urinary Ca excretion, indicating better Ca absorption.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to the editor regarding \"Racial disparities in the utilization and outcomes of robotic bariatric surgery: an 8-year analysis of Metabolic and Bariatric Surgery Accreditation Quality Improvement Program data\".","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1016/j.soard.2024.10.032","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.032","url":null,"abstract":"","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142645313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Liposomal bupivacaine for sleeve gastrectomy is associated with improved opioid outcomes and lower odds of opioid use disorder: claims-based analysis.","authors":"Jon Gould, Andras Sandor, Jennifer H Lin, Swapnabir Kakoty, Mary DiGiorgi, Karl A LeBlanc","doi":"10.1016/j.soard.2024.10.024","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.024","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing bariatric surgery may be at increased risk for postsurgical opioid dependence, highlighting a need for opioid-sparing anesthesia.</p><p><strong>Objectives: </strong>Liposomal bupivacaine (LB), a prolonged release formulation of bupivacaine, may improve postoperative pain management and reduce postsurgical opioid use. This retrospective claims-database study investigated the effects of LB versus non-LB analgesia on opioid use and healthcare resource utilization (HCRU) in patients receiving laparoscopic sleeve gastrectomy (SG).</p><p><strong>Setting: </strong>Retrospective study using the IQVIA linkage claims database.</p><p><strong>Methods: </strong>Data from patients aged ≥18 years and free of opioid prescriptions within the prior 6 months undergoing inpatient laparoscopic SG between January 1, 2016, and December 31, 2019, were analyzed. Outcomes included perioperative opioid use in oral morphine milligram equivalents (MMEs), opioid-related adverse events (ORAEs), postdischarge HCRU, continued (>2 weeks to 3 months postdischarge) and persistent (4-6 months postdischarge) opioid use, and opioid use disorder (OUD) at 6 months.</p><p><strong>Results: </strong>Of 4298 patients (2149 in each cohort), LB was associated with significantly fewer perioperative opioids (100.53 versus 155.48 MMEs; mean difference, -54.95 [95% confidence interval (CI), -64.46, -45.45]; P < .0001), lower rates of in-hospital ORAEs (9.63% versus 13.82%; odds ratio [OR], .67 [95% CI, .55, .80]; P < .0001), significantly lower incidence of OUD (.09% versus .51%; OR, .18 [95% CI, .04, .82]; P = .026), shorter hospital length of stay (P = .0008), and significantly lower odds of 30-day postdischarge hospital readmissions (P = .025) versus non-LB analgesia.</p><p><strong>Conclusions: </strong>LB reduced opioid use, in-hospital ORAEs, OUD, and hospital readmissions after laparoscopic SG.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of predictors of acute kidney injury and progression to chronic kidney disease following bariatric surgery.","authors":"Kamal Abi Mosleh, Lauren Lu, Marita Salame, Noura Jawhar, Juraj Sprung, Toby Weingarten, Omar M Ghanem","doi":"10.1016/j.soard.2024.10.025","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.025","url":null,"abstract":"<p><strong>Background: </strong>Despite the overall safety of metabolic and bariatric surgery (MBS), the potential for postoperative complications such as acute kidney injury (AKI) remains a critical concern. Decade-old studies from our institution reported rates of AKI following MBS between 5.8% and 8.6%, with factors such as higher body mass index (BMI), diabetes, and hypertension identified as potential contributors. However, the incidence and factors associated with AKI following MBS have remained underexplored in contemporary literature.</p><p><strong>Objectives: </strong>To investigate the incidence and risk factors associated with postoperative AKI, as well as the potential for progression to CKD and renal failure.</p><p><strong>Setting: </strong>Quaternary academic medical center with a high-volume MBS practice.</p><p><strong>Methods: </strong>A retrospective review of adult patients undergoing primary laparoscopic MBS between 2008 and 2022 to identify patients who developed AKI, defined as postoperative increase in serum creatinine (sCr) by .3 mg/dL within 72 hours. A multivariable logistic regression was constructed to identify potential AKI risk factors.</p><p><strong>Results: </strong>Among 1697 patients, the incidence of AKI was 3.0% (n = 51). The distribution of AKI was not significantly different between procedure types. There was no significant correlation between anesthesia medications given and the occurrence of AKI. Male gender was the most significant predictor of AKI (adjusted odds ratio [aOR] = 3.87, 95% confidence interval {CI} [2.14-6.99]), followed by hypertension (aOR = 2.12, 95% CI [1.03-4.83]) and longer surgical duration (aOR = 1.19, 95% CI [1.05-1.35]) per 30 minutes. Of those who developed AKI, 7 (13.7%) required dialysis acutely for management, while 3 patients (5.9%) progressed to chronic renal failure and required transplant.</p><p><strong>Conclusions: </strong>AKI is a rare but serious complication following MBS that occurs in approximately 3% of cases. AKI incidence is higher in male patients, those with hypertension, insulin-requiring diabetes, renal insufficiency, and longer procedure durations. Heightened awareness of the identified risk factors should help guide patient selection, and additional efforts should be directed towards refining postoperative follow-up.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between metabolic and bariatric surgery and malignancy: a systematic review, meta-analysis, trends, and conclusions.","authors":"Libi-Or Madar, Nitzan Goldberg, Uri Netz, Iosefina Francesca Berenstain, Ez El Din Abu Zeid, Itzhak Avital, Zvi H Perry","doi":"10.1016/j.soard.2024.10.023","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.023","url":null,"abstract":"<p><strong>Background: </strong>Conflicting studies have investigated the association between obesity, metabolic and bariatric surgery (MBS), and cancer.</p><p><strong>Objectives: </strong>Our study aimed at elucidating the trends in cancer incidence that are related to obesity and weight loss managed through MBSs, like Colo-rectal, breast, uterine, and esophageal cancer.</p><p><strong>Setting: </strong>We conducted a search using PubMed, Embase, and the Cochrane Library electronic databases through May 2020.</p><p><strong>Methods: </strong>A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement.</p><p><strong>Results: </strong>MBS procedures surveyed included sleeve gastrectomy, gastric band, gastric bypass, gastric balloon, and banded gastroplasty/silastic ring gastroplasty. The initial search found 11,789 potential studies. After data extraction and filtering, 21 were included in the final analysis. Overall, the calculated risk of cancer was reduced after MBS in comparison to the patients suffering from obesity who were treated nonoperatively (mean effect size of -.33). It was also found as a protective factor against colorectal cancer (mean E.S. -.28), uterine cancer (mean E.S. -.42), breast cancer (mean E.S. -.37), and esophageal cancer (mean E.S. -.23). Other cancers, such as liver, pancreatic, and skin, did not show a significant change even though a trend was seen.</p><p><strong>Conclusions: </strong>According to the data retrieved from patients who underwent MBS compared to nonoperated patients suffering from obesity, the overall risk for malignancy was lower in the MBS group. Additional information collected in this study revealed the behavior of specific types of cancer in response to induced weight loss by operative means. The benefit of surgery in patients suffering from obesity is not restricted to the improvement of obesity morbidity alone.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of surgical technique on gastroesophageal reflux disease after laparoscopic sleeve gastrectomy: a nationwide observational study.","authors":"Saif Al-Tai, Stephan Axer, Eva Szabo, Johan Ottosson, Erik Stenberg","doi":"10.1016/j.soard.2024.10.033","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.033","url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic sleeve gastrectomy (LSG) has gained increasing popularity worldwide, yet concerns persist regarding the development of gastroesophageal reflux disease (GERD) postoperatively.</p><p><strong>Objectives: </strong>This study aimed to evaluate the influence of technical aspects of LSG, specifically bougie size and distance from the pylorus to resection line edge, on the risk of developing symptomatic GERD within 2years following surgery.</p><p><strong>Setting: </strong>Data from the Scandinavian Obesity Surgery Registry (SOReg) and the National Prescribed Drug Register were utilized for this analysis.</p><p><strong>Methods: </strong>A retrospective observational study was conducted encompassing all LSG patients in Sweden between 2012 and 2020 who did not receive preoperative proton pump inhibitor (PPI) prescriptions. Patients were categorized based on bougie size and pyloric distance. Regular PPI use, defined as a dispensed prescription of more than 300 tablets per year, was employed as a proxy measure of symptomatic GERD and was compared between the groups.</p><p><strong>Results: </strong>The study included 7,435 patients with complete data on dispensed PPI prescription both preoperatively and throughout the 2-year follow-up period. Information on bougie size and pyloric distance was available for 97.4% and 84.9%, respectively. Narrower bougie size and greater pyloric distance were associated with increased risk of regular PPI use postsurgery. Advanced age and female sex were independent risk factors for post-LSG regular PPI use, while initial body mass index (BMI), total weight loss (%TWL), and comorbidities showed no significant associations.</p><p><strong>Conclusions: </strong>Using a narrow bougie and initiating resection at a greater distance from the pylorus were associated with higher risk of symptomatic de novo GERD following LSG.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The trend of atherogenic indices in patients with type 2 diabetes after bariatric surgery: a national cohort study.","authors":"Arsalan Seyedi, Soghra Rabizadeh, Faeze Abbaspour, Sahar Karimpour Reyhan, Nasrin Asgari Soran, Ali Nabipoor, Amirhossein Yadegar, Fatemeh Mohammadi, Rana Hashemi, Reihane Qahremani, Elahe Saffari, Sajedeh Riazi, Fatemeh Sarv, Manouchehr Nakhjavani, Abdolreza Pazouki, Alireza Esteghamati","doi":"10.1016/j.soard.2024.10.022","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.022","url":null,"abstract":"<p><strong>Background: </strong>Bariatric surgery has profound effects on weight loss, metabolic regulation, and gut hormone modulation, which make it an efficient tool for managing obesity and improving diabetes outcomes.</p><p><strong>Objectives: </strong>The objective of this study is to evaluate the atherogenic indices, including atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli's risk index II (CRI-II), and lipoprotein combine index (LCI) in individuals with type 2 diabetes (T2D) living with excess weight, who have undergone bariatric surgery.</p><p><strong>Setting: </strong>Three types of surgery including one-anastomosis gastric bypass/mini gastric bypass (OAGB/MGB), sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB) were performed on patients with obesity and T2D in the period of August 2009 to February 2021 at the Surgical Department of Hazrat-e Rasool Hospital (University Hospital), Tehran, Iran.</p><p><strong>Methods: </strong>In this retrospective cohort, 1246 individuals with obesity and T2D who underwent 3 types of bariatric surgery including RYGB, SG, and OAGB/MGB were studied for 2years after the surgery; the data were derived from the National Iranian Obesity Surgery Database. Afterward, the trend of biochemical parameters, total weight loss (TWL%), and atherogenesis-related indices were evaluated from baseline up to 2years in 5 follow-up visits.</p><p><strong>Results: </strong>A total of 1246 patients with T2D and obesity who underwent bariatric surgery were included in this study. The trend of all atherogenesis-related indices, including AIP, LCI, CRI-II, and AC, showed a significant reduction (49.2%, 53.4%, 20.8%, 22%, respectively) 2years after the bariatric surgery (P < .05). In the 6-month follow-up, 1-year follow-up, and 2-year follow-up, 1023 (83.10%), 719 (57.70%), and 341 (27.36%) individuals participated, respectively. In addition, a significant increase in high-density lipoprotein cholesterol levels was observed 2years after the surgery in both sexes (P < .05).</p><p><strong>Conclusions: </strong>The bariatric surgery significantly reduced the levels of atherogenic indices including AIP, CRI-II, LCI, and AC.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of emergent reoperations after bariatric surgery: an important metric for safe same-day surgery.","authors":"Ahmad M Hider, Aaron J Bonham, Sarah Petersen, Amanda Stricklen, Rachel Ross, Jonathan F Finks, Arthur M Carlin, Oliver A Varban","doi":"10.1016/j.soard.2024.10.026","DOIUrl":"https://doi.org/10.1016/j.soard.2024.10.026","url":null,"abstract":"<p><strong>Background: </strong>Early reoperation after sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) is a severe adverse event that may increase the risk of perioperative mortality if there is a delay in care. However, it is unclear what proportion of reoperations occur within 24 hours of surgery and who is at greater risk, which may impact the safety of performing safe same-day surgery.</p><p><strong>Objectives: </strong>To evaluate the incidence of reoperation in the first 24 hours after primary SG and RYGB.</p><p><strong>Setting: </strong>Michigan Bariatric Surgery Collaborative, Ann Arbor, Michigan.</p><p><strong>Methods: </strong>Using a statewide bariatric surgery data registry, patients undergoing primary SG (n = 49,848) and RYGB (n = 11,267) cases were analyzed. Patients who had a subsequent reoperation were identified and reasons for reoperation were compared between those occurring <24 hours versus >24 hours. In addition, patients who underwent a reoperation <24 hours were compared with patients who underwent primary SG or RYGB and did not experience any complications.</p><p><strong>Results: </strong>The overall rate of reoperation was .72% for SG and 2.1% for RYGB. Reoperation <24 hours of index procedure was 32.0% after SG and 24.2%, after gastric bypass, with the most common reason being hemorrhage (86.15%% and 55.4% respectively). Older age, hypertension, liver disease, and longer operative times were associated with reoperation <24 hours after SG, whereas longer operative times were associated with reoperation <24 hours after RYGB. Concurrent hiatal hernia repair was not associated with increased risk.</p><p><strong>Conclusions: </strong>Reoperation after primary bariatric surgery is rare but occurs within 24 hours in approximately one third of the cases after SG and one quarter of cases after RYGB. Older patients with significant comorbidities are at increased risk and should be considered poor candidates for same-day surgery given the possibility of an early life-threatening event.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}